Role of B7H4 and CD48 in EAE
Role of B7H4 and CD48 in EAE
批准号:
7568196
负责人:
Arlene H. Sharpe
金额:
$45.54万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2010-01-31
关键词:
AddressAutoimmune DiseasesAutoimmunityB-LymphocytesCD58 AntigensDisease susceptibilityExperimental Autoimmune EncephalomyelitisFamily memberGeneticGoalsHomologous GeneHumanInsulin-Dependent Diabetes MellitusLeadMediatingMultiple SclerosisMusNumbersOrganPhaseProcessRoleSignal TransductionT-Cell ActivationT-LymphocyteTissuesTransgenic MiceUpper armin vivoinsightmigrationnovelresponsetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall goal is to dissect the functional roles of the recently identified B7 family member, B7-H4, and the SLAM family member, CD48 (a CD2 ligand), in regulating organ-specific
autoimmune diseases. This focus is driven by recent genetic studies of Multiple Sclerosis and murine type 1 diabetes that have implicated the genetic locus that contains these costimulatory molecules (human or mouse homologues) with disease susceptibility, together with our recent studies that point to important roles for B7-H4 and CD48 in regulating T cell activation and
tolerance. To investigate the roles of B7-H4 and CD48-mediated signals in the afferent arm of the response where T cells become activated in the periphery, and in the effector arm, where potentially pathogenic T cells are driven to mediate tissue destruction, we are proposing a multifaceted approach. We will 1)investigate the role of the B7-H4 in regulating T cell tolerance and autoimmunity; 2)analyze the role of CD48 in regulating the induction and effector phases of EAE; and 3)examine the roles of CD48 and B7-H4 in regulating T and B cell tolerance. We have assembled a number of novel tools that will enable us to address these important issues. To dissect the role of B7-H4 in EAE, we have developed B7-H4lg and anti-B7-H4 mAb. We also
have available B7-H4-/- mice and are in the process of generating transgenic mice that inducibly express B7-H4. Our CD48-/- mice, and anti-CD48 mAb will serve as definitive tools for examining the role of CD48 during EAE. We will use MOG 35-55 specific TCR transgenic mice to visualize
the effects of B7-H4 and CD48 dysregulation on the activation, migration and expansion of naive and activated T cells in vivo, and MOG 35-55 TCR x Th double transgenic mice to analyze the roles of B7-H4 and CD48 in regulating B and T cell tolerance to MOG. Taken together, these studies should lead to insights into how B7-H4 and CD48 costimulatory regulate the responses of self-reactive T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining regulators of immunity to acute infection using CRISPR screens
-
批准号:10210502
-
项目类别:
-
资助金额:$10.99万
-
财政年份:2020
-
负责人:Arlene H. Sharpe
-
依托单位:
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
-
批准号:10153453
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2018
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 2: Measuring and modeling the tumor and immune microenvironment before and during therapy and at the time of drug resistance
-
批准号:10343840
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2018
-
负责人:Arlene H. Sharpe
-
依托单位:
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
-
批准号:9906872
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2018
-
负责人:Arlene H. Sharpe
-
依托单位:
Abbreviated targeted therapy to improve anti-PD-1 inhibitor efficacy in melanoma
-
批准号:9576657
-
项目类别:
-
资助金额:$39.83万
-
财政年份:2018
-
负责人:Arlene H. Sharpe
-
依托单位:
Defining regulators of immunity to acute infection using CRISPR screens
-
批准号:10207344
-
项目类别:
-
资助金额:$229.25万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1: CRISPR screens to discover regulators of CD8 and CD4 cell fates and function
-
批准号:10207349
-
项目类别:
-
资助金额:$86.54万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
Defining regulators of immunity to acute infection using CRISPR screens
-
批准号:9380804
-
项目类别:
-
资助金额:$246.29万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
Core D: Mouse Perturbation Core
-
批准号:10207348
-
项目类别:
-
资助金额:$81.28万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
Administrative Core
-
批准号:10207345
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
Defining regulators of immunity to acute infection using CRISPR screens
-
批准号:10266219
-
项目类别:
-
资助金额:$10.99万
-
财政年份:2017
-
负责人:Arlene H. Sharpe
-
依托单位:
T Cell Costimulatory Pathways: Function and Interactions
-
批准号:9121451
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2016
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1: Costimulation and Regulation of Anti-viral Immunity
-
批准号:9121455
-
项目类别:
-
资助金额:$53.35万
-
财政年份:2016
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
-
批准号:10023668
-
项目类别:
-
资助金额:$47.04万
-
财政年份:2015
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
-
批准号:10239110
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2015
-
负责人:Arlene H. Sharpe
-
依托单位:
Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
-
批准号:8854452
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2015
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
-
批准号:10670295
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2015
-
负责人:Arlene H. Sharpe
-
依托单位:
Project 1 - Modulation of Tolerance and Autoimmunity by Inhibitory Receptors
-
批准号:10663576
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2015
-
负责人:Arlene H. Sharpe
-
依托单位:
Role of Costimulation in Control of the Effector and Regulatory T Cell Balance
-
批准号:8289441
-
项目类别:
-
资助金额:$62.9万
-
财政年份:2011
-
负责人:Arlene H. Sharpe
-
依托单位:
Role of Immune Regulatory Pathways in BRAF Targeted Therapy In Melanoma
-
批准号:8555326
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2011
-
负责人:Arlene H. Sharpe
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: